# ZCCHC9

## Overview
ZCCHC9 is a gene that encodes the zinc finger CCHC-type containing 9 protein, which is characterized by its four CCHC-type zinc finger motifs. These motifs are integral to the protein's function in binding nucleic acids, such as RNA and single-stranded DNA, and facilitating protein-protein interactions. The protein is primarily localized in the nucleus, particularly the nucleolus, and plays a significant role in RNA metabolism and ribosome biogenesis. It is involved in the Mitogen-Activated Protein Kinase (MAPK) signaling pathway, where it acts as a regulatory factor by suppressing transcription activities of NF-kappa B and SRE, thereby influencing cell differentiation and response to extracellular signals. Additionally, ZCCHC9 has been implicated in various pathological conditions, including cancer and neurodevelopmental disorders, due to its role in transcription regulation and RNA processing (Zhou2008A; Homs2016Genetic; AceitunoValenzuela2020Genomewide).

## Structure
ZCCHC9 is a human nuclear protein characterized by the presence of four retroviral-type zinc knuckle motifs, which are involved in RNA or single-stranded DNA binding (Sanudo20101H). These motifs are a type of zinc finger domain, specifically CCHC-type, which are known for their role in nucleic acid interactions. The primary structure of ZCCHC9 includes sequences rich in cysteine and histidine residues, essential for coordinating zinc ions that stabilize the protein's conformation. 

The secondary structure of ZCCHC9 likely includes alpha helices and beta sheets, common in proteins with zinc finger domains, although specific details are not provided in the context. The tertiary structure is influenced by the coordination of zinc ions, which help maintain the protein's three-dimensional shape necessary for its function in RNA binding. 

ZCCHC9 is expressed at high levels in the mouse brain and testicles and is upregulated in certain human cancers, suggesting a role in cellular processes that may involve post-translational modifications such as phosphorylation or ubiquitination, although specific modifications are not detailed in the context (Sanudo20101H). The protein's involvement in RNA quality control and potential participation in the MAPK signaling cascade indicate its functional significance, though the exact mechanisms remain unclear.

## Function
The ZCCHC9 gene encodes a protein that is primarily localized in the nucleus, specifically in the nucleolus, and is highly expressed in the brain, particularly in the cerebral cortex, as well as in the testicles (Zhou2008A). This protein contains four CCHC-type zinc finger motifs, which are known for their roles in DNA and RNA binding, as well as mediating protein-protein interactions (Zhou2008A). ZCCHC9 is involved in the Mitogen-Activated Protein Kinase (MAPK) signaling pathway, where it suppresses the transcription activities of NF-kappa B and SRE, indicating a regulatory role in cellular processes such as cell differentiation and response to extracellular signals (Zhou2008A).

In addition to its role in the MAPK pathway, ZCCHC9 is considered a ribosome biogenesis factor, as its knockdown results in the over-accumulation of 21S pre-rRNA, a precursor of 18S rRNA, suggesting its involvement in rRNA processing (AceitunoValenzuela2020Genomewide). This indicates that ZCCHC9 plays a significant role in RNA metabolism and ribosome biogenesis, impacting gene expression and cellular function.

## Clinical Significance
ZCCHC9 has been implicated in various diseases due to its role in transcription regulation and RNA processing. In non-small cell lung cancer, overexpression of ZCCHC9 is associated with increased transcription of p-JNK, Cyclin D1, and MMP7, which promotes cancer cell proliferation and invasion, suggesting its contribution to cancer progression (Wang2021The). In thyroid carcinoma, ZCCHC9 expression is higher in patients compared to normal controls and shows a positive correlation with immune cells such as B cells, macrophages, neutrophils, and CD8+ T cells, indicating its potential role in tumor immunity and as a biomarker for diagnosis (Yin2023Differential).

In the context of autism spectrum disorders (ASD), increased methylation in the promoter region of ZCCHC9 correlates with its downregulation, suggesting that epigenetic alterations in this gene may contribute to ASD pathology (Homs2016Genetic). Although specific diseases directly resulting from mutations in ZCCHC9 are not detailed, its altered expression and methylation patterns are linked to significant clinical outcomes in cancer and neurodevelopmental disorders. These findings highlight the potential clinical significance of ZCCHC9 in various pathological conditions.

## Interactions
ZCCHC9, a protein encoded by the human gene ZCCHC9, is involved in several interactions with other proteins and cellular pathways. In the context of non-small cell lung cancer (NSCLC), ZCCHC9 is primarily located in the cytoplasm and is associated with the promotion of cancer cell proliferation and invasion. This effect is mediated through the JNK signaling pathway, where ZCCHC9 overexpression leads to the upregulation of phosphorylated JNK (p-JNK) and downstream molecules such as Cyclin D1 and MMP7. The JNK pathway inhibitor SP600125 can reduce these effects, indicating that ZCCHC9's role in cancer progression is closely linked to its interaction with the JNK pathway (Shi2019ZCCHC9).

Additionally, there is a potential interaction between ZCCHC9 and HSP72, a known regulator of the JNK pathway. The co-addition of HSP72 siRNA with ZCCHC9 overexpression abolishes the effect of ZCCHC9 on p-JNK regulation, suggesting a regulatory interaction between these proteins (Shi2019ZCCHC9).

In a different cellular context, ZCCHC9 is localized in the nucleus, particularly in the nucleolus, and is involved in suppressing the MAPK signaling pathway. It achieves this by reducing the transcriptional activities of NF-kappa B and SRE, indicating a role in transcription regulation and potential interactions with components of the MAPK pathway (Zhou2008A).


## References


[1. (Yin2023Differential) Yin Yin, Jing Chen, Qian Chen, Hongyan He, Nannan Zhu, Pengcheng Xia, Chunli Yu, and Lingyun Meng. Differential expression of zinc finger cchc-type superfamily proteins in thyroid carcinoma and their associations with tumor immunity. Thyroid Research, October 2023. URL: http://dx.doi.org/10.1186/s13044-023-00185-1, doi:10.1186/s13044-023-00185-1. This article has 0 citations.](https://doi.org/10.1186/s13044-023-00185-1)

[2. (Sanudo20101H) Maria Sanudo, Martin Jacko, Christiane Rammelt, Stepanka Vanacova, and Richard Stefl. 1h, 13c, and 15n chemical shift assignments of zcchc9. Biomolecular NMR Assignments, 5(1):19–21, August 2010. URL: http://dx.doi.org/10.1007/s12104-010-9257-2, doi:10.1007/s12104-010-9257-2. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12104-010-9257-2)

[3. (Zhou2008A) Aidong Zhou, Jianlin Zhou, Liping Yang, Mingjun Liu, Hong Li, Su Xu, Mei Han, and Jian Zhang. A nuclear localized protein zcchc9 is expressed in cerebral cortex and suppresses the mapk signal pathway. Journal of Genetics and Genomics, 35(8):467–472, August 2008. URL: http://dx.doi.org/10.1016/s1673-8527(08)60064-8, doi:10.1016/s1673-8527(08)60064-8. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s1673-8527(08)60064-8)

[4. (Homs2016Genetic) A Homs, M Codina-Solà, B Rodríguez-Santiago, C M Villanueva, D Monk, I Cuscó, and L A Pérez-Jurado. Genetic and epigenetic methylation defects and implication of the ermn gene in autism spectrum disorders. Translational Psychiatry, 6(7):e855–e855, July 2016. URL: http://dx.doi.org/10.1038/tp.2016.120, doi:10.1038/tp.2016.120. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/tp.2016.120)

[5. (Shi2019ZCCHC9) Xiuying Shi, Biying Jiang, Haifeng Liu, and Chuifeng Fan. Zcchc9 promotes proliferation and invasion of lung cancer through regulating the jnk pathway. Journal of Cellular Biochemistry, 120(6):10596–10604, January 2019. URL: http://dx.doi.org/10.1002/jcb.28346, doi:10.1002/jcb.28346. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.28346)

[6. (Wang2021The) Yishu Wang, Yu Yu, Yidan Pang, Haojun Yu, Wenqi Zhang, Xian Zhao, and Jianxiu Yu. The distinct roles of zinc finger cchc-type (zcchc) superfamily proteins in the regulation of rna metabolism. RNA Biology, 18(12):2107–2126, May 2021. URL: http://dx.doi.org/10.1080/15476286.2021.1909320, doi:10.1080/15476286.2021.1909320. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15476286.2021.1909320)

[7. (AceitunoValenzuela2020Genomewide) Uri Aceituno-Valenzuela, Rosa Micol-Ponce, and María Rosa Ponce. Genome-wide analysis of cchc-type zinc finger (zcchc) proteins in yeast, arabidopsis, and humans. Cellular and Molecular Life Sciences, 77(20):3991–4014, April 2020. URL: http://dx.doi.org/10.1007/s00018-020-03518-7, doi:10.1007/s00018-020-03518-7. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-020-03518-7)